Kyverna Therapeutics (KYTX) Interest Coverage Ratio (2023 - 2026)
Kyverna Therapeutics (KYTX) posted Interest Coverage Ratio of 1.18 for Q1 2026, up 89.52% on a QoQ basis from 11.24 in Q4 2025, and up 97.61% year-over-year from 0.6 in Q1 2025.
Kyverna Therapeutics (KYTX) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
Kyverna Therapeutics' Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 1.18 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 97.61% year-over-year to 1.18 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.66 (up 91.46% YoY) and the FY2025 annual result came in at 3.88, up 91.65% from the prior year.
- Interest Coverage Ratio was 1.18 for Q1 2026 at Kyverna Therapeutics, up from 11.24 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 13.51 in Q4 2023 and bottomed at 49.23 in Q1 2025.
- A 4-year average of 13.67 and a median of 13.87 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2025 — Interest Coverage Ratio slumped 676.42% — and 2026, when it soared 97.61%.
- Kyverna Therapeutics' Interest Coverage Ratio stood at 13.51 in 2023, then plunged by 202.68% to 13.87 in 2024, then gained by 18.99% to 11.24 in 2025, then jumped by 89.52% to 1.18 in 2026.
- Business Quant data shows KYTX's Interest Coverage Ratio at 1.18 in Q1 2026, 11.24 in Q4 2025, and 2.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Kyverna Therapeutics | 440.57 Mn | 440.57 Mn | - | -1.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.18 |
| Dec 31, 2025 | -11.24 |
| Sep 30, 2025 | -2.40 |
| Jun 30, 2025 | -20.55 |
| Mar 31, 2025 | -49.23 |
| Dec 31, 2024 | -13.87 |
| Sep 30, 2024 | -4.37 |
| Jun 30, 2024 | -2.65 |
| Mar 31, 2024 | -16.33 |
| Dec 31, 2023 | 13.51 |
| Sep 30, 2023 | -27.05 |
| Jun 30, 2023 | -22.10 |
| Mar 31, 2023 | -20.26 |